EP Patent

EP3596077A1 — Analogs of deutetrabenazine, their preparation and use

Assigned to Auspex Pharmaceuticals Inc · Expires 2020-01-22 · 6y expired

What this patent protects

The disclosure is directed to deutetrabenazine analogs, compositions comprising same and methods of detecting same in compositions comprising deutetrabenazine.

USPTO Abstract

The disclosure is directed to deutetrabenazine analogs, compositions comprising same and methods of detecting same in compositions comprising deutetrabenazine.

Drugs covered by this patent

Patent Metadata

Patent number
EP3596077A1
Jurisdiction
EP
Classification
—
Expires
2020-01-22
Drug substance claim
No
Drug product claim
No
Assignee
Auspex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.